Clinical Trials | October 16, 2021
Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
Since its inception, the company has either acquired or taken a majority stake in five companies
This product will be manufactured at Lupin’s Pithampur facility In India
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
The aspirant can enrol in MBA (Healthcare and Hospital Management) at Ganpat University, -Centre for Management Studies and Research, which will be facilitated by Ganpat University and Shalby Centre for Healthcare Management and Research
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
Subscribe To Our Newsletter & Stay Updated
